Update - Page 73

COLEFAX GROUP PLC (“Colefax” or “the Group”) AGM STATEMENT Colefax will hold its Annual General Meeting at 11.00am this morning and David Green, Chief…

26 September 2024  Tagrisso approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer Based on LAURA Phase III trial results which showed Tagrisso extended…

23 September 2024 Datopotamab deruxtecan final overall survival results reported in patients with metastatic HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III…

18 September 2024 MJ Gleeson plc (GLE.L) (“Gleeson” or “the Group” or “the Company”) Audited results for the year ended 30 June 2024 (“FY2024”)…

Strong sales, a prime portfolio and an improving outlook underpin increased dividend Henry Boot PLC, a Company engaged in land promotion, property investment and…

GSK plc (LSE/NYSE: GSK) today announced that it has completed the primary objective data analysis from the phase II part of the TH HSV…

James Cropper plc (“James Cropper”, the “Company” or the “Group”) AGM Trading Update James Cropper (AIM: CRPR), the Advanced Materials and Paper & Packaging…

RNS Announcement: USA Results Baillie Gifford US Growth Trust plc (‘USA’) Results for the year ended 31 May 2024 During the financial year to 31…